|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
SCIDIR_ocn874161742 |
| 003 |
OCoLC |
| 005 |
20231120111543.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
790629s1979 enka ob 101 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d OPELS
|d OCLCF
|d YDXCP
|d EBLCP
|d N$T
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 870587480
|
| 020 |
|
|
|a 9781483159775
|q (electronic bk.)
|
| 020 |
|
|
|a 1483159779
|q (electronic bk.)
|
| 020 |
|
|
|z 008023089X
|
| 020 |
|
|
|z 9780080230894
|
| 035 |
|
|
|a (OCoLC)874161742
|z (OCoLC)870587480
|
| 050 |
|
4 |
|a RM315
|b .C58 1979eb
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615/.78
|
| 110 |
2 |
|
|a Collegium Internationale Neuro-psychopharmacologicum,
|j issuing body.
|
| 245 |
1 |
0 |
|a Neuro-psychopharmacology :
|b proceedings of the 11th congress of the Collegium Internationale Neuro-psychopharmacologium, Vienna, July 9-14, 1978 /
|c editors, B. Saletu, P. Berner, L. Hollister.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Oxford :
|b Pergamon Press,
|c 1979.
|
| 300 |
|
|
|a 1 online resource (751 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover image; Title page; Table of Contents; Copyright; C.I.N.P. COMMITTEES; 11th C.I.N.P. CONGRESS COMMITTEES; ACKNOWLEDGEMENTS; Chapter 1: Presidential Address; Publisher Summary; ECT IN DEPRESSION: BIOCHEMICAL EFFECTS AND MODE OF ACTION; Chapter 2: Summary; Publisher Summary; Chapter 3: Long Lasting Effects of ECT on Monoaminergic Mechanisms; ABSTRACT; INTRODUCTION; METHODS; RESULTS AND DISCUSSION; CONCLUDING REMARKS; Chapter 4: Enhanced Monoamine Behavioural Responses Following Repeated Electroconvulsive Shock to Rats and their Relevance to ECT; ABSTRACT; INTRODUCTION; METHODS.
|
| 505 |
8 |
|
|a RESULTSCONCLUSIONS; ACKNOWLEDGEMENTS; Chapter 5: ECT Effects on Mineral Metabolism and Neuroendocrine Function; ABSTRACT; INTRODUCTION; PROBLEMS INHERENT TO CLINICAL INVESTIGATION OF CALCIUM METABOLISM IN PSYCHIATRIC PATIENTS; RATIONALE FOR STUDIES OF CALCIUM METABOLISM IN PSYCHIATRIC PATIENTS; DATA REVIEW; MECHANISMS ACCOUNTING FOR OBSERVED CHANGES IN CALCIUM METABOLISM; CONCLUSION; Chapter 6: Convulsive Therapy in Depression: A Neurohumoral and Neuroendocrine Theory; Publisher Summary; GENETIC ASPECTS OF PSYCHOPHARMACOLOGY.
|
| 505 |
8 |
|
|a Chapter 7: The HLA System and the Celinical Response to Treatment with HaloperidolABSTRACT; INTRODUCTION; MATERIALS AND METHODS; RESULTS; DISCUSSION; Chapter 8: Genetic Components in the Mechanism of Action of Lithium: HLA-Antigens and the Response to Prophylactic Lithium; ABSTRACT; Chapter 9: Genetics and Lithium Ion Metabolism in Affective Disorders; ABSTRACT; INTRODUCTION; SAMPLE AND METHODS; RESULTS; B. Lithium Ratio, Affective Diagnosis and Lithium Prophylaxis; C. Extra and Intracellular Lithium Concentrations; DISCUSSION; ACKNOWLEDGMENTS.
|
| 505 |
8 |
|
|a Chapter 10: Pharmacogenetics and the Pharmacologic Challenge Strategy in Clinical Research: Studies of D-Amphetamine and ArecolineABSTRACT; INTRODUCTION; METHODS; RESULTS; DISCUSSION; Chapter 11: Functional Activitiy of Brain Monoamine Oxidase; ABSTRACT; INTRODUCTION; MULTIPLE FORMS OF MAO AND SELECTIVE INHIBITORS; THE ROLE OF 5-HT. DA AND MAO IN THE PRODUCTION OF HYPERACTIVITY SYNDROME; A. 5-HYDROXYTRYPTAMINE (5-HT); B. DOPAMINE (DA); C. FUNCTIONAL ACTIVITY OF MONOAMINE OXIDASE (MAO); MAO ACTIVITY IN PSYCHIATRIC DISEASES.
|
| 505 |
8 |
|
|a THE CLINICAL USE OF MAO 'TYPE B' INHIBITORS IN THE TREATMENT OF DEPRESSION AND PARKINSON'S DISEASEChapter 12: Biochemical Genetics and Platelet MAO; ABSTRACT; INTRODUCTION; A POSSIBLE MICHAELIS CONSTANT ABNORMALITY; BIOLOGICAL RESEARCH IN DEPRESSION AND MANIA; Chapter 13: Serotonin in Depressive Illness -- Studies of CSF 5-HIAA; ABSTRACT; INTRODUCTION; RESULTS AND DISCUSSION; COMMENTS; ACKNOWLEDGEMENTS; Chapter 14: Obsessive-Compulsive Disorders: A Serotonergic Hypothesis; ABSTRACT; INTRODUCTION; Chapter 15: Noradrenergic Function in Affective Illness; ABSTRACT; CONCLUSIONS.
|
| 650 |
|
0 |
|a Neuropsychopharmacology
|v Congresses.
|
| 650 |
|
6 |
|a Neuropsychopharmacologie
|0 (CaQQLa)201-0006772
|v Congr�es.
|0 (CaQQLa)201-0378219
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Neuropsychopharmacology
|2 fast
|0 (OCoLC)fst01036504
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|0 (OCoLC)fst01423772
|
| 700 |
1 |
|
|a Saletu, Bernd.
|
| 700 |
1 |
|
|a Berner, P.
|q (Peter)
|
| 700 |
1 |
|
|a Hollister, Leo E.,
|d 1920-2000.
|
| 776 |
0 |
8 |
|i Print version:
|a Collegium Internationale Neuro-psycho-pharmacologium.
|t Neuro-psychopharmacology : proceedings of the 11th congress of the Collegium Internationale Neuro-psychopharmacologium, Vienna, July 9-14, 1978.
|d Oxford : Pergamon Press, 1979
|h xiii, 736 pages ; 26 cm.
|z 9780080230894
|w (DLC) 79040552
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080230894
|z Texto completo
|
